Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of switching from Subutex to Suboxone in opioid-dependent adults
2006-005234-21Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in opioid use disorder (OUD) and substance use disorder (SUD) comparing Switch to Suboxone with Remain on Subutex (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2007; status: completed.
02
Drugs
Suboxonebuprenorphine
03
Conditions
opioid use disorder (OUD)substance use disorder (SUD)
Beyond the preview
Go deeper on 2006-005234-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005234-21.